Japan Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End User, and Region 2025-2033

Description

Japan next-generation sequencing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.9 Billion by 2033, exhibiting a growth rate (CAGR) of 22.4% during 2025-2033. The escalating incidence of chronic diseases, such as cancer and genetic disorders, which has increased the demand for advanced genetic testing and sequencing technologies, is driving the market.

Next-generation sequencing (NGS) is a high-throughput, massively parallel DNA sequencing technology that enables the rapid and cost-effective analysis of entire genomes, transcriptomes, and epigenomes. NGS simultaneously sequences millions of DNA fragments, allowing for the generation of large volumes of data in a single run. This technology has revolutionized genomics research and biomedical applications by facilitating the study of genetic variations, gene expression patterns, and the identification of disease-causing mutations. NGS has diverse applications, including whole-genome sequencing, exome sequencing, RNA sequencing, and ChIP sequencing, among others. It has significantly accelerated the pace of biological and medical research, contributing to advances in personalized medicine, disease diagnosis, and the understanding of complex biological processes. However, challenges such as data analysis, storage, and interpretation remain, requiring the development of robust bioinformatics tools and computational techniques to fully harness the potential of NGS in various scientific fields.

Japan Next-Generation Sequencing Market Trends:

The next-generation sequencing market in Japan is experiencing rapid growth, largely fueled by several key factors. Firstly, the increasing prevalence of chronic diseases regionally has heightened the demand for advanced diagnostic tools, propelling the adoption of NGS technologies. Consequently, healthcare providers are increasingly integrating NGS into their clinical practices, aiming to offer personalized treatments and enhance patient outcomes. Moreover, the plummeting costs associated with genome sequencing have significantly broadened the accessibility of NGS platforms, thereby encouraging their widespread utilization across research and clinical settings. Additionally, the escalating focus on precision medicine and the rising significance of genomics in drug discovery and development has bolstered the demand for NGS, fostering collaborations between biotechnology firms and research institutions to expedite the translation of genomic insights into targeted therapies. Furthermore, the continual advancements in bioinformatics tools and data analysis techniques, which have facilitated the interpretation of complex genomic data, thereby stimulating the adoption of NGS technologies in various fields, are expected to drive the NGS market in Japan during the forecast period.

Japan Next-Generation Sequencing Market Segmentation:

Sequencing Type Insights:

Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
Others

Product Type Insights:

Instruments
Reagents and Consumables
Software and Services

Technology Insights:

Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others

Application Insights:

Biomarker and Cancer
Drug Discovery and Personalized Medicine
Genetic Screening
Diagnostics
Agriculture and Animal Research
Others

End User Insights:

Academic Institutes and Research Centers
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan next-generation sequencing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan next-generation sequencing market?
What is the breakup of the Japan next-generation sequencing market on the basis of sequencing type?
What is the breakup of the Japan next-generation sequencing market on the basis of product type?
What is the breakup of the Japan next-generation sequencing market on the basis of technology?
What is the breakup of the Japan next-generation sequencing market on the basis of application?
What is the breakup of the Japan next-generation sequencing market on the basis of end user?
What are the various stages in the value chain of the Japan next-generation sequencing market?
What are the key driving factors and challenges in the Japan next-generation sequencing?
What is the structure of the Japan next-generation sequencing market and who are the key players?
What is the degree of competition in the Japan next-generation sequencing market?

Product Code: SR112025A19919

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Next-Generation Sequencing Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Next-Generation Sequencing Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Next-Generation Sequencing Market - Breakup by Sequencing Type

6.1 Whole Genome Sequencing
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Targeted Resequencing
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Whole Exome Sequencing
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 RNA Sequencing
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 CHIP Sequencing
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 De Novo Sequencing
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
6.7 Methyl Sequencing
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2019-2024)
- 6.7.3 Market Forecast (2025-2033)
6.8 Others
- 6.8.1 Historical and Current Market Trends (2019-2024)
- 6.8.2 Market Forecast (2025-2033)

7 Japan Next-Generation Sequencing Market - Breakup by Product Type

7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Reagents and Consumables
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Software and Services
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)

8 Japan Next-Generation Sequencing Market - Breakup by Technology

8.1 Sequencing by Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Ion Semiconductor Sequencing
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Single-Molecule Real-Time Sequencing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Nanopore Sequencing
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Next-Generation Sequencing Market - Breakup by Application

9.1 Biomarker and Cancer
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Drug Discovery and Personalized Medicine
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Genetic Screening
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Diagnostics
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Agriculture and Animal Research
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
9.6 Others
- 9.6.1 Historical and Current Market Trends (2019-2024)
- 9.6.2 Market Forecast (2025-2033)

10 Japan Next-Generation Sequencing Market - Breakup by End User

10.1 Academic Institutes and Research Centers
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Hospitals and Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Pharmaceutical and Biotechnology Companies
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Others
- 10.4.1 Historical and Current Market Trends (2019-2024)
- 10.4.2 Market Forecast (2025-2033)

11 Japan Next-Generation Sequencing Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Next-Generation Sequencing Market - Industry Analysis

13.1 Drivers, Restraints and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis